Merit Medical Q1 2020 Earnings Report
Key Takeaways
Merit Medical reported a 2.2% increase in worldwide revenue for Q1 2020, reaching $243.5 million. However, the company experienced a GAAP loss per share of $(0.06), compared to a GAAP EPS of $0.11 in Q1 2019. Non-GAAP EPS was $0.38, slightly up from $0.37 in Q1 2019. Due to the uncertainty caused by the COVID-19 pandemic, Merit Medical has withdrawn its FY 2020 guidance.
Worldwide revenue increased by 2.2% to $243.5 million compared to Q1 2019.
Core revenue on a constant currency basis increased by 3.0% over Q1 2019.
GAAP loss per share was $(0.06), compared to GAAP EPS of $0.11 in Q1 2019.
Non-GAAP EPS was $0.38, compared to $0.37 in Q1 2019.
Merit Medical
Merit Medical
Merit Medical Revenue by Segment
Forward Guidance
Due to the general uncertainty related to the coronavirus pandemic and corresponding economic downturn, Merit’s management has concluded that it cannot issue financial guidance for the remainder of 2020. As such, Merit’s previously issued 2020 guidance is withdrawn until further notice.
Revenue & Expenses
Visualization of income flow from segment revenue to net income